Cardiometabolic Outcomes and Mortality in Patients with Adrenal Adenomas in a Population-based Setting:A Population-Based Cohort Study
| Autor: | Zhang, Catherine D, Li, Dingfeng, Kaur, Ravinder Jeet, Ebbehoj, Andreas, Singh, Sumitabh, Atkinson, Elizabeth J, Achenbach, Sara J, Young, William F, Arlt, Wiebke, Rocca, Walter A, Bancos, Irina |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Male
Adult Epidemiology Adrenal Gland Neoplasms/physiopathology prevalence Adrenal Gland Neoplasms adrenal incidentaloma Minnesota/epidemiology Metabolic Diseases/epidemiology cardiovascular events adrenal mass Young Adult Humans Mortality Aged Aged 80 and over Cardiovascular Diseases/epidemiology Cardiovascular disease (CVD) Middle Aged Prognosis cardiovascular outcomes Survival Rate Cardiovascular death incidence Female Adrenocortical Adenoma/physiopathology Morbidity Follow-Up Studies |
| Zdroj: | Zhang, C D, Li, D, Kaur, R J, Ebbehoj, A, Singh, S, Atkinson, E J, Achenbach, S J, Young, W F, Arlt, W, Rocca, W A & Bancos, I 2021, ' Cardiometabolic Outcomes and Mortality in Patients with Adrenal Adenomas in a Population-based Setting : A Population-Based Cohort Study ', The Journal of clinical endocrinology and metabolism, vol. 106, no. 11, pp. 3320-3330 . https://doi.org/10.1210/clinem/dgab468 |
| DOI: | 10.1210/clinem/dgab468 |
| Popis: | Context: While adrenal adenomas have been linked with cardiovascular morbidity in convenience samples of patients from specialized referral centers, large-scale population-based data are lacking. Objective: To determine the prevalence and incidence of cardiometabolic disease and assess mortality in a population-based cohort of patients with adrenal adenomas. Design: Population-based cohort study. Setting: Olmsted County, Minnesota, USA. Patients: Patients diagnosed with adrenal adenomas without overt hormone excess and age- and sex-matched referent subjects without adrenal adenomas. Main outcome measure: Prevalence, incidence of cardiometabolic outcomes, mortality. Results: (Adrenal adenomas were diagnosed in 1004 patients (58% women, median age 63 years) from 1/01/1995 to 12/31/2017. At baseline, patients with adrenal adenomas were more likely to have hypertension [adjusted odds ratio (aOR) 1.96, 95% CI 1.58-2.44], dysglycemia (aOR 1.63, 95% CI 1.33-2.00), peripheral vascular disease (aOR 1.59, 95% CI 1.32-2.06), heart failure (aOR 1.64, 95% CI 1.15-2.33), and myocardial infarction (aOR 1.50, 95% CI 1.02-2.22) compared to referent subjects. During median follow-up of 6.8 years, patients with adrenal adenomas were more likely than referent subjects to develop de novo chronic kidney disease [adjusted hazard ratio (aHR) 1.46, 95% CI 1.14-1.86], cardiac arrhythmia (aHR 1.31, 95% CI 1.08-1.58), peripheral vascular disease (aHR 1.28, 95% CI 1.05-1.55), cardiovascular events (aHR 1.33, 95% CI 1.01-1.73), and venous thromboembolic events (aHR 2.15, 95% CI 1.48-3.13). Adjusted mortality was similar between the 2 groups. Conclusion: Adrenal adenomas are associated with an increased prevalence and incidence of adverse cardiometabolic outcomes in a population-based cohort. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|